Monitoring asthma in childhood : Management-related issues by ERS Task Force Monitoring Asthma in Children
Monitoring asthma in childhood:
management-related issues
Bart L. Rottier1, Ernst Eber2, Gunilla Hedlin3,4, Steve Turner5, Edwina Wooler6,
Eva Mantzourani7 and Neeta Kulkarni8 on behalf of the ERS Task Force
Monitoring Asthma in Children9
Affiliations: 1Dept of Pediatric Pulmonology and Allergology, GRIAC Research Institute, University Medical
Center Groningen, University of Groningen, Groningen, The Netherlands. 2Respiratory and Allergic Disease
Division, Dept of Paediatrics and Adolescence Medicine, Medical University of Graz, Graz, Austria. 3Dept of
Women’s and Children’s Health and Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden.
4Astrid Lindgren Children’s Hospital, Stockholm, Sweden. 5Dept of Paediatrics, University of Aberdeen,
Aberdeen, UK. 6Royal Alexandra Children’s Hospital, Brighton, UK. 7Dept of Paediatrics, University Hospital of
Heraklion, University of Crete, Heraklion, Greece. 8Leicestershire Partnership Trust and Dept of Infection,
Immunity and Inflammation, University of Leicester, Leicester, UK. 9A full list of the ERS Task Force
Monitoring Asthma in Children members and their affiliations can be found in the acknowledgements section.
Correspondence: Bart L. Rottier, Dept of Pediatric Pulmonology and Allergology, GRIAC Research Institute,
University Medical Center Groningen, University of Groningen, PO Box 30001, 9700 RB Groningen, The
Netherlands. E-mail: b.l.rottier@umcg.nl
ABSTRACT Management-related issues are an important aspect of monitoring asthma in children in clinical
practice. This review summarises the literature on practical aspects of monitoring including adherence to
treatment, inhalation technique, ongoing exposure to allergens and irritants, comorbid conditions and side-effects
of treatment, as agreed by the European Respiratory Society Task Force on Monitoring Asthma in Childhood.
The evidence indicates that it is important to discuss adherence to treatment in a non-confrontational
way at every clinic visit, and take into account a patient’s illness and medication beliefs. All task force
members teach inhalation techniques at least twice when introducing a new inhalation device and then at
least annually. Exposure to second-hand tobacco smoke, combustion-derived air pollutants, house dust
mites, fungal spores, pollens and pet dander deserve regular attention during follow-up according to most
task force members. In addition, allergic rhinitis should be considered as a cause for poor asthma control.
Task force members do not screen for gastro-oesophageal reflux and food allergy. Height and weight are
generally measured at least annually to identify individuals who are susceptible to adrenal suppression and
to calculate body mass index, even though causality between obesity and asthma has not been established.
In cases of poor asthma control, before stepping up treatment the above aspects of monitoring deserve
closer attention.
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Introduction
Monitoring is essential to reach the ultimate goal of asthma treatment: obtaining clinical control and
reducing future risks to a child with asthma.
Recently, a European Respiratory Society Task Force on Monitoring Asthma in Childhood was published
[1]. In the present review we aim to discuss aspects of monitoring related to the management of children
with asthma in more detail. Monitoring adherence to treatment, inhalation technique and side-effects of
management are issues that should be routinely checked. In the case of poorly controlled asthma other
factors might be considered, such as persistent exposure to tobacco smoke or allergens. This review also
covers conditions that may aggravate asthma (e.g. allergic rhinitis, environmental irritant exposure and
obesity) or that may become apparent during follow-up. Three other articles in this issue of the European
Respiratory Review will address general considerations on monitoring asthma in children, monitoring
symptoms, exacerbations and quality of life, and monitoring lung function, bronchial responsiveness and
inflammation [2–4]. As no formal grading of the evidence was conducted, this statement does not contain
recommendations for clinical practice.
Adherence to treatment
According to the World Health Organization, adherence to treatment is defined as the extent to which a
person’s behaviour (taking medication, following a diet and/or executing lifestyle changes) corresponds
with agreed recommendations from a healthcare provider. Although concordance has more recently been
used to express the collaborative relationship between care takers and care providers on the basis of
equality, adherence is more commonly used and is, therefore, used in this review.
Poor adherence to medication is common in chronic conditions, and patients’ and parents’ illness and
medication beliefs are by far the most consistent and strongest predictors of adherence to inhaled
corticosteroids (ICS), the mainstay of treatment for children with persistent asthma [5–8].
Scheduled close follow-up of children with asthma, providing repeated tailored education, agreement on
treatment goals and methods, and addressing patients’ and parents’ beliefs and concerns, helps to improve
asthma control [6, 9, 10]. As adherence to ICS is strongly associated with asthma control, improving
adherence, compared to any improvement in specific medical treatment, may be the most cost-effective
way to improve asthma control [11, 12]. In children with problematic asthma, medication issues and issues
on prevention of exposures contributed to poor asthma control in nearly half of the children [13].
Taken together, the evidence indicates that adherence to maintenance treatment is a matter that warrants
attention at each appointment with a healthcare provider, in particular in children with poorly controlled asthma.
How to measure adherence
There is no gold standard to measure adherence to treatment. Interviews and self-reporting by patients
and/or parents tend to overestimate adherence. Face-to-face interviews have been demonstrated to be more
effective than computer-assisted or written interviews in reporting adherence, but still overestimates
adherence to treatment [14]. Pharmacy refill rates seem to be as equally unreliable as self-reported
adherence [15]. Electronic data recording may be the most reliable way to assess adherence, however, this
should be balanced against extra costs [14]. In a recent study in 2–6-year-old children, electronically
recorded adherence demonstrated a relatively high median adherence rate of 92% (interquartile range
76–97%) over a 3-month period [16]. Importantly, parents who believed that ICS maintenance therapy
was needed for their child’s health, those who viewed ICS administration as convenient and those who
expected little harm from medication had higher adherence rates to ICS. This evidence suggests that all
these are important issues for follow-up visits of children with asthma.
In clinical trials where electronic monitoring was applied, adherence was ∼70% for all diseases that needed
twice daily dosing of medication [17].
In general, an increasing number of daily doses leads to decreased adherence, even in clinical trials,
although the effect is small [17]. In real life, adherence can therefore often be expected to be lower.
Additional risk factors for poor adherence are growing up in single parent families, replacement of the
caregiver, lower education of the mother and prescribing more than two inhalations a day [18, 19]. In
most studies a link between education level and adherence was not shown.
Motivational interviewing is a patient-centred approach to discuss behaviour change by helping children
or their parents to say why and how they might change [20]. A systematic review that included 72 studies
(no paediatric studies) found that motivational interviewing outperformed traditional advice given in 80%
of studies [21]. The evidence suggests that adherence can be improved by applying specific communicative
consultation skills [22].
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All task force members discuss adherence to treatment at every patient visit and a non-confrontational way
of interviewing may be preferred, which may be sufficient in children with mild-to-moderate disease.
However, in children with severe, uncontrolled asthma, assessing adherence by electronic measurement or
directly observed therapies is more reliable and might be considered. If these are unavailable, prescription
records or refill rates could provide useful information. In some cases home visits may be useful. Educational
interventions alone are insufficient to enhance medication adherence in children and adolescents [23].
Inhaler technique
After adequate adherence to treatment, correct inhaler technique is a prerequisite of successful asthma
treatment. Correct inhaler technique involves using an age appropriate device, handling the device
correctly and performing an (age dependent) adequate breathing manoeuvre [24]. Healthcare professionals
should demonstrate any asthma inhaler device that a child needs to use to the child and their family and
then have the child or parent demonstrate how they would use the device [25]. Less than one-third of
asthmatic children receiving treatment with a dry powder inhaler performed all essential steps correctly
compared with 67% of children using a pressurised metered dose inhaler (pMDI)/spacer combination
[26]. Repeated instruction led to improved performance compared to a single instruction given by a
general practitioner [26].
In younger children it may be necessary to demonstrate to the parents how to hold a child securely to aid
treatment administration, particularly with a spacer and facemask. Furthermore, patients should be actively
encouraged to ask questions regarding asthma medication devices [25]. In adults, there is evidence that a
patient is more likely to correctly use an inhaler that they like [27]. Although in general it is logical to
provide both anti-inflammatory and rescue medication in one type of inhaler, concurrent use of pMDIs
and dry powder inhalers (DPIs) by children did not adversely affect spacer/inhalation technique in an
observational study [28].
It has been well documented that children learn through play and utilising some simple play strategies can
improve inhaler technique. Placing stickers on spacers, distracting children with nursery rhymes or videos
and trying to make the whole experience fun rather than a stressful intervention can help with the
acceptance of inhaler devices. Although appealing, this is not supported by strong evidence; for example, an
attractive spacer device like the “funhaler” did not improve adherence or asthma control [29, 30].
In order to achieve and maintain a correct inhalation technique, the procedure has to be taught and
checked and taught again; the number of newly referred patients demonstrating a correct inhalation
technique improved from 57.4 to 97.9% after three comprehensive instruction sessions [31]. Telepharmacy
counselling via interactive compressed video (which allows real-time video and audio interaction between
individuals in different physical locations) was superior to education provided via written instructions on
an inhaler package insert in adolescents with asthma [32]. Instruction of inhaler technique by telephone
resulted in an improvement in inhaler technique both for pMDIs and for DPIs in adults [33]. Also,
repeated instruction by a respiratory therapist led to a relevant improvement in inhaler technique [34].
Although it might be anticipated that combination inhalers improve adherence compared with the use of
separate inhalers, this was not demonstrated in a randomised controlled trial [35].
The evidence indicates that inhaler technique is improved if taught, repeated back and checked at least
twice when new drugs or devices are prescribed, with deteriorating asthma control or at least annually.
The European Respiratory Society/International Society for Aerosols in Medicine consensus paper
provides detailed recommendations on checking inhalation technique and states that this should be
performed regularly and that adherence should be reviewed at every visit. Furthermore, this paper
recommends not switching to a new device without the patient’s involvement or without follow-up
education on how to use the device properly [24].
Side-effects of drug treatment
During long-term use of low-to-moderate doses of ICS (beclometasone 200–400 µg·day−1 or equivalent),
the risk of systemic side-effects is very low [36, 37]. Height growth may be reduced by approximately
0.5–2 cm during the first 1–2 years of treatment [38]; whether or not this persists over time a matter of
debate [39, 40]. Even if the effect is persistent, the advantages of ICS maintenance therapy outweigh its
risks [37]. Although more serious systemic side-effects, such as adrenal suppression, are almost exclusively
seen during treatment with high-dose ICS, they may occur in children on low-dose ICS [41]. Children
using high doses of ICS warrant monitoring for possible adrenal suppression. More research is needed to
define which adrenal suppression tests are useful and in which children. Most members of the task force
would consider nasal and topical corticosteroids when assessing total corticosteroid dose.
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Local side-effects, such as thrush and hoarseness, are rare and easily manageable by teeth brushing or
mouth rinsing after administration of ICS [42]. Apart from monitoring height growth, which is mandatory
for all paediatric chronic conditions, there is no need to monitor children with asthma with respect to
potential side-effects of ICS maintenance therapy. Height and weight should be measured at least annually
but preferably at every routine visit [43]. It may be important to discuss the fear of side-effects with
parents during the clinic visits.
Monitoring diseases that may aggravate asthma
Food allergy, obesity and gastro-oesophageal reflux are conditions that may present simultaneously with
asthma, may aggravate asthma or may mimic asthma. Their potential role has recently been reviewed and
therefore is only discussed briefly here [44]. It may be necessary to identify these comorbidities and treat
them accordingly, particularly in those with poor asthma control.
Asthmatic children with rhinitis, compared with those without, have been reported to have poorer asthma
control, reduced quality of life, increased risk for emergency visits or hospitalisations and higher
healthcare costs [45–48]. Signs and symptoms suggestive of rhinitis and rhinosinusitis are described in
table 1. Most physicians ask about these symptoms and look for them at least annually. Although
treatment for rhinitis has not been proven to improve asthma control, it is considered good practice to
ensure that rhinitis symptoms are managed appropriately in a child with asthma.
Food allergy is commonly considered to be a risk factor for poor asthma control based on its association
with severe and even fatal asthma exacerbations [49, 50]. However, it should be realised that the diagnosis
of food allergy was not based on the gold standard for food allergy, the double-blind, placebo-controlled
food challenge, in any of these studies. As up to 80% of children sensitised to a certain food do not show
clinical allergy following oral ingestion of the food [51, 52], most studies assessed sensitisation for foods
and not allergy as a risk factor. Most patients with sensitisation to foods are also sensitised to
aeroallergens, which is associated with a distinct, clinically more severe, atopic phenotype [53]. Therefore,
it is not the food allergy per se but sensitisation to multiple foods and aeroallergens that may be a risk
factor for poor asthma control or severe exacerbations. In children with asthma, without any history of
adverse reactions to foods, the members of the task force do not screen for food allergy. Children with
asthma with confirmed food allergy and anaphylaxis might receive an adrenalin auto injector after
appropriate training in its use [54].
Gastro-oesophageal reflux can trigger cough in children, whether they are asthmatic or not [55, 56]. Based
on largely descriptive small studies, gastro-oesophageal reflux has been suggested to cause impaired
asthma control in children but there is limited data to support this. Usually these studies do not include
an adequate control group and a causal link between gastro-oesophageal reflux and asthma symptoms
TABLE 1 Symptoms and signs of rhinitis/rhinosinusitis




Nasal itching (check for allergic salute, allergic crease and shiners)
Atypical manifestations of (allergic) rhinitis
Cough (check for post-nasal drip)
Eustachian tube dysfunction
Secretory otitis media and effusion/ask if otitis media occurs frequently
Decreased hearing (speech and language delay, child speaks loudly, child increases TV sound)
Poor school performance/poor concentration
Consider hearing test/audiometry
Sleep problems
Disturbed sleep (ask about fatigue/irritability, poor concentration and school performance)
Snoring
Apnoea (check for hypertrophy of adenoids or of tonsils and consider a sleep study)
Symptoms and signs of rhinosinusitis
Cough
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could not be proven. The results from two controlled studies do not support wide-spread use of
oesophageal pH testing in children with asthma who have symptoms despite being on controller
medication [57, 58]. Treatment with lansoprazole in children with poorly controlled asthma, without
symptoms of gastro-oesophageal reflux, did not improve symptoms or lung function. Therefore, diagnostic
testing for gastro-oesophageal reflux has no role in monitoring asthma in children.
The relationship between obesity and asthma is complex and not yet fully understood. Being overweight
per se is known to induce respiratory symptoms such as dyspnoea and wheezing which can mimic asthma
[59, 60]. Furthermore, obesity can have metabolic effects that contribute to airway inflammation [61, 62].
Comorbidity, including gastro-oesophageal reflux and obstructive sleep apnoea, may present symptoms
that mimic asthma. More studies are needed to establish whether poorly controlled asthma leads to a more
sedentary lifestyle and increasing obesity or whether obesity in itself decreases asthma control and, if so,
whether it is just symptoms or also objective measures of control [63]. In obese patients with uncontrolled
asthma it is probably not sufficient to rely on symptoms alone. Exercise testing and/or measurement of
markers of airway inflammation may be useful. Therefore, the task force members monitor weight and
height in children with asthma in order to record body mass index.
Environmental factors
Multiple environmental agents are known to worsen asthma symptoms; in this section only the most
common indoor and outdoor environmental factors will be discussed, such as tobacco smoke,
combustion-derived air pollutants, house dust mites, fungal spores, pollens and pet dander.
Tobacco smoke
There is good evidence that second-hand tobacco smoke exposure causes asthma, more severe asthma
symptoms, bronchial hyperresponsiveness, airways inflammation and adverse effects on respiratory health
in children and adolescents [64–67]. Studies in emergency departments have identified that children
presenting with wheeze are more likely to be exposed to second-hand tobacco smoke compared with those
presenting with other conditions and that second-hand tobacco smoke exposure is weakly associated with
more severe acute asthma [66, 68]. Due to ethical considerations, no study has deliberately exposed
children to second-hand tobacco smoke in a randomised controlled trial, but intervention studies have
sought to reduce second-hand tobacco smoke exposure in children with asthma with mixed success. In a
study where asthma education included awareness of second-hand tobacco smoke exposure, exposure was
reduced in only 17% of households but children living in these households experienced a 50% decrease in
the number of hospital admissions over the following year [69]. A second study in children with asthma,
of whom 50% were exposed to second-hand tobacco smoke, aimed at reducing second-hand tobacco
smoke exposure by educating the parents, in combination with a high efficiency particulate air filter in the
child’s bedroom and allergen reduction interventions [70]. Children who received the intervention had
reduced symptoms and exacerbations during the 1-year trial plus the subsequent year but the intervention
was not associated with a reduction in the number of households with smokers. A third study recruited
young children with asthma whose parents smoked and studied an educational intervention, which
included feedback on the child’s urinary cotinine; the intervention was associated with reduced
exacerbations but a nonsignificant reduction in urinary cotinine [71]. A better understanding of how to
motivate parents of children with asthma to change their smoking habits is required and once this has
been achieved the impact of such an intervention on asthma exacerbations and control should be
evaluated [72, 73].
Self-reported exposure to second-hand tobacco smoke by parents and older children is generally unreliable
[74]. There are several methods (measurements of cotinine, hair or nail nicotine, exhaled carbon
monoxide and airborne nicotine) to objectively measure children’s exposure to second-hand tobacco
smoke but no gold standard. Currently there is no single recommended method for monitoring
second-hand tobacco smoke exposure in children with asthma.
Air pollution
Outdoor air pollution is a mixture of multiple toxic chemicals and gases, with varying composition
depending on the source and meteorological conditions. Children appear to be more vulnerable to health
effects of air pollution than adults due to a higher minute ventilation, higher levels of physical activity
outdoors and that fact that their lungs are still developing [75–78]. A recent review, which included 20
studies in children investigating evidence of air pollution causing exacerbations of respiratory symptoms,
found a high consistency of positive association [79]. This conclusion was similar to an earlier extensive
review conducted by the World Health Organization [80]. In a more recent study of 40 children living
near roads, SPIRA-COHEN et al. [81] showed that the relative risk for shortness of breath, wheeze and total
symptoms was associated with personal elemental carbon exposure. In Greece, mean daily concentrations
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of particles with a 50% cut-off aerodynamic diameter of 10 μm were significantly related to asthma
admissions over a 4-year period in 3600 children [82].
There is also a positive association between exposure to traffic-related air pollution and reduced growth in
lung function [83]. The measurement of outdoor pollutants is mainly carried out for regulatory purposes
and is currently not used in clinical settings to monitor children with asthma.
The most common source of indoor pollutants is incomplete combustion of biomass and solid fuels (e.g.
dung, wood, agricultural residues, charcoal and coal) [84], kerosene, candles and incense [85, 86], and
mosquito coils [87]. Exposure to mosquito coil smoke is common among working class populations in
warm climates [88]. Chronic exposure is associated with bronchial irritation, increased sputum production
and persistent wheeze in children [88–90]. A recent study from Taiwan, in which 3764 school children
(mean age 12 years) were evaluated, demonstrated that the frequency of incense burning at home was
associated with an increased risk of current asthma, medication use and exercise-induced wheeze [87].
Indoor dampness is another important factor that is associated with a higher risk of asthma [91, 92].
Environmental allergen load
Common aeroallergens include house dust mites, pollens, pet allergens and fungal spores. In a recent
review it was concluded that chemical and physical measures aimed at reducing house dust mite exposure
could not be recommended; however, the meta-analysis was considered flawed for various reasons [93, 94].
In a large study of 937 inner city children with asthma, individualised environmental intervention
programmes reduced exposure to indoor allergens and resulted in decreased asthma morbidity [70].
Most task force members ask specific questions, tailored to the local environment, about exposures likely
to increase the risk of asthma or to trigger asthma exacerbations and these questions should be included in
the assessment of all asthmatic children (table 2). Regional pollen counts are freely available on TV or the
internet, and these may guide patients and parents in strategies to manage a potential increase in
symptoms. Environmental manipulation within the home should be multifaceted, and may incur the
family a great deal of time and expense with the possibility that the benefits may be limited. Most task
force members do not take single measures to reduce allergen load as they are likely to be of little benefit.
The evidence for routine home visits to children with asthma to assess the environmental allergen load is
limited, but such visits may be part of the work-up of children with persistent severe asthma before any
changes or increase in treatment regimens are considered [95].
Socioeconomic circumstances
Low education of parents is associated with under treatment of children with asthma and risk of
exacerbations [7]. Socially disadvantaged children with asthma have elevated asthma morbidity including
more emergency room visits. Less access to quality healthcare and medications, more environmental
exposures (including allergens, pollution and environmental tobacco smoke), psychosocial stress, exposure
to violence and belonging to a minority group may all account for this [96]. It may be speculated that
improving social and educational factors may improve asthma management in these children.
Conclusion
Monitoring of asthma in children includes an evaluation of adherence on every check-up. Current practice
by task force members is to teach inhalation technique at least twice when new drugs or devices are
prescribed, and then at least annually or with deteriorating asthma control.
TABLE 2 Possible pollutants/exposures for discussion with parents and children in the clinic/
during a home visit
Second-hand tobacco smoke
Traffic density near home/school
Industries near home/school
Cooking: use of wood/gas




Chemicals used at home for cleaning
Use of incense sticks/candles
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Apart from the generally accepted monitoring of height gain, there is no need to monitor children with
asthma with respect to potential side-effects of ICS therapy. Particularly in children with poor asthma
control, it is practice to screen for allergic or nonallergic rhinitis/rhinosinusitis and treat accordingly.
There is no evidence to use oesophageal pH testing in asthmatic children who have symptoms despite use
of controller medication. Task force members do not screen for food allergy, except in children with a
history suggesting food allergy and asthma.
All task force members educate parents about the possible environmental agents (e.g. second-hand tobacco
smoke, other air pollutants) triggering asthma exacerbations. Single measures to reduce allergen loads are
likely to be of little benefit.
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